Global Artificial Intelligence Drug R&D Market 2023 by Company, Regions, Type and Application, Forecast to 2029
Artificial Intelligence Drug R&D means that we use AI (narrow AI for now, which specilizing in few tasks) to generate and analyse immense amounts of biological and outcomes data from patients or chem database to predict new targets, or to conclude standard models.
According to our (Global Info Research) latest study, the global Artificial Intelligence Drug R&D market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Artificial Intelligence Drug R&D market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Artificial Intelligence Drug R&D market size and forecasts, in consumption value ($ Million), 2018-2029
Global Artificial Intelligence Drug R&D market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Artificial Intelligence Drug R&D market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Artificial Intelligence Drug R&D market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Artificial Intelligence Drug R&D
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Artificial Intelligence Drug R&D market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include IBM Watson, BioXel, Insilico Medicine, Gatehouse Bio and Google DeepMind, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Artificial Intelligence Drug R&D market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Artificial Intelligence Drug R&D product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Artificial Intelligence Drug R&D, with revenue, gross margin and global market share of Artificial Intelligence Drug R&D from 2018 to 2023.
Chapter 3, the Artificial Intelligence Drug R&D competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Artificial Intelligence Drug R&D market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Artificial Intelligence Drug R&D.
Chapter 13, to describe Artificial Intelligence Drug R&D research findings and conclusion.
According to our (Global Info Research) latest study, the global Artificial Intelligence Drug R&D market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Artificial Intelligence Drug R&D market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Artificial Intelligence Drug R&D market size and forecasts, in consumption value ($ Million), 2018-2029
Global Artificial Intelligence Drug R&D market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Artificial Intelligence Drug R&D market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Artificial Intelligence Drug R&D market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Artificial Intelligence Drug R&D
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Artificial Intelligence Drug R&D market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include IBM Watson, BioXel, Insilico Medicine, Gatehouse Bio and Google DeepMind, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Artificial Intelligence Drug R&D market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- AI Platfrom
- Analytics Service
- Drug Discovery
- Precision Medicine
- IBM Watson
- BioXel
- Insilico Medicine
- Gatehouse Bio
- Google DeepMind
- Genpact Cora
- Cyclica Inc
- QuantumBlack
- Nq Medical
- Phenomic AI
- Palantir Technologies
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Artificial Intelligence Drug R&D product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Artificial Intelligence Drug R&D, with revenue, gross margin and global market share of Artificial Intelligence Drug R&D from 2018 to 2023.
Chapter 3, the Artificial Intelligence Drug R&D competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Artificial Intelligence Drug R&D market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Artificial Intelligence Drug R&D.
Chapter 13, to describe Artificial Intelligence Drug R&D research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Artificial Intelligence Drug R&D
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Artificial Intelligence Drug R&D by Type
1.3.1 Overview: Global Artificial Intelligence Drug R&D Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Artificial Intelligence Drug R&D Consumption Value Market Share by Type in 2022
1.3.3 AI Platfrom
1.3.4 Analytics Service
1.4 Global Artificial Intelligence Drug R&D Market by Application
1.4.1 Overview: Global Artificial Intelligence Drug R&D Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Drug Discovery
1.4.3 Precision Medicine
1.5 Global Artificial Intelligence Drug R&D Market Size & Forecast
1.6 Global Artificial Intelligence Drug R&D Market Size and Forecast by Region
1.6.1 Global Artificial Intelligence Drug R&D Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Artificial Intelligence Drug R&D Market Size by Region, (2018-2029)
1.6.3 North America Artificial Intelligence Drug R&D Market Size and Prospect (2018-2029)
1.6.4 Europe Artificial Intelligence Drug R&D Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Artificial Intelligence Drug R&D Market Size and Prospect (2018-2029)
1.6.6 South America Artificial Intelligence Drug R&D Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Artificial Intelligence Drug R&D Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 IBM Watson
2.1.1 IBM Watson Details
2.1.2 IBM Watson Major Business
2.1.3 IBM Watson Artificial Intelligence Drug R&D Product and Solutions
2.1.4 IBM Watson Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 IBM Watson Recent Developments and Future Plans
2.2 BioXel
2.2.1 BioXel Details
2.2.2 BioXel Major Business
2.2.3 BioXel Artificial Intelligence Drug R&D Product and Solutions
2.2.4 BioXel Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 BioXel Recent Developments and Future Plans
2.3 Insilico Medicine
2.3.1 Insilico Medicine Details
2.3.2 Insilico Medicine Major Business
2.3.3 Insilico Medicine Artificial Intelligence Drug R&D Product and Solutions
2.3.4 Insilico Medicine Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Insilico Medicine Recent Developments and Future Plans
2.4 Gatehouse Bio
2.4.1 Gatehouse Bio Details
2.4.2 Gatehouse Bio Major Business
2.4.3 Gatehouse Bio Artificial Intelligence Drug R&D Product and Solutions
2.4.4 Gatehouse Bio Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Gatehouse Bio Recent Developments and Future Plans
2.5 Google DeepMind
2.5.1 Google DeepMind Details
2.5.2 Google DeepMind Major Business
2.5.3 Google DeepMind Artificial Intelligence Drug R&D Product and Solutions
2.5.4 Google DeepMind Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Google DeepMind Recent Developments and Future Plans
2.6 Genpact Cora
2.6.1 Genpact Cora Details
2.6.2 Genpact Cora Major Business
2.6.3 Genpact Cora Artificial Intelligence Drug R&D Product and Solutions
2.6.4 Genpact Cora Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Genpact Cora Recent Developments and Future Plans
2.7 Cyclica Inc
2.7.1 Cyclica Inc Details
2.7.2 Cyclica Inc Major Business
2.7.3 Cyclica Inc Artificial Intelligence Drug R&D Product and Solutions
2.7.4 Cyclica Inc Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Cyclica Inc Recent Developments and Future Plans
2.8 QuantumBlack
2.8.1 QuantumBlack Details
2.8.2 QuantumBlack Major Business
2.8.3 QuantumBlack Artificial Intelligence Drug R&D Product and Solutions
2.8.4 QuantumBlack Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 QuantumBlack Recent Developments and Future Plans
2.9 Nq Medical
2.9.1 Nq Medical Details
2.9.2 Nq Medical Major Business
2.9.3 Nq Medical Artificial Intelligence Drug R&D Product and Solutions
2.9.4 Nq Medical Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Nq Medical Recent Developments and Future Plans
2.10 Phenomic AI
2.10.1 Phenomic AI Details
2.10.2 Phenomic AI Major Business
2.10.3 Phenomic AI Artificial Intelligence Drug R&D Product and Solutions
2.10.4 Phenomic AI Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Phenomic AI Recent Developments and Future Plans
2.11 Palantir Technologies
2.11.1 Palantir Technologies Details
2.11.2 Palantir Technologies Major Business
2.11.3 Palantir Technologies Artificial Intelligence Drug R&D Product and Solutions
2.11.4 Palantir Technologies Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Palantir Technologies Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Artificial Intelligence Drug R&D Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Artificial Intelligence Drug R&D by Company Revenue
3.2.2 Top 3 Artificial Intelligence Drug R&D Players Market Share in 2022
3.2.3 Top 6 Artificial Intelligence Drug R&D Players Market Share in 2022
3.3 Artificial Intelligence Drug R&D Market: Overall Company Footprint Analysis
3.3.1 Artificial Intelligence Drug R&D Market: Region Footprint
3.3.2 Artificial Intelligence Drug R&D Market: Company Product Type Footprint
3.3.3 Artificial Intelligence Drug R&D Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Artificial Intelligence Drug R&D Consumption Value and Market Share by Type (2018-2023)
4.2 Global Artificial Intelligence Drug R&D Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Artificial Intelligence Drug R&D Consumption Value Market Share by Application (2018-2023)
5.2 Global Artificial Intelligence Drug R&D Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Artificial Intelligence Drug R&D Consumption Value by Type (2018-2029)
6.2 North America Artificial Intelligence Drug R&D Consumption Value by Application (2018-2029)
6.3 North America Artificial Intelligence Drug R&D Market Size by Country
6.3.1 North America Artificial Intelligence Drug R&D Consumption Value by Country (2018-2029)
6.3.2 United States Artificial Intelligence Drug R&D Market Size and Forecast (2018-2029)
6.3.3 Canada Artificial Intelligence Drug R&D Market Size and Forecast (2018-2029)
6.3.4 Mexico Artificial Intelligence Drug R&D Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Artificial Intelligence Drug R&D Consumption Value by Type (2018-2029)
7.2 Europe Artificial Intelligence Drug R&D Consumption Value by Application (2018-2029)
7.3 Europe Artificial Intelligence Drug R&D Market Size by Country
7.3.1 Europe Artificial Intelligence Drug R&D Consumption Value by Country (2018-2029)
7.3.2 Germany Artificial Intelligence Drug R&D Market Size and Forecast (2018-2029)
7.3.3 France Artificial Intelligence Drug R&D Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Artificial Intelligence Drug R&D Market Size and Forecast (2018-2029)
7.3.5 Russia Artificial Intelligence Drug R&D Market Size and Forecast (2018-2029)
7.3.6 Italy Artificial Intelligence Drug R&D Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Artificial Intelligence Drug R&D Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Artificial Intelligence Drug R&D Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Artificial Intelligence Drug R&D Market Size by Region
8.3.1 Asia-Pacific Artificial Intelligence Drug R&D Consumption Value by Region (2018-2029)
8.3.2 China Artificial Intelligence Drug R&D Market Size and Forecast (2018-2029)
8.3.3 Japan Artificial Intelligence Drug R&D Market Size and Forecast (2018-2029)
8.3.4 South Korea Artificial Intelligence Drug R&D Market Size and Forecast (2018-2029)
8.3.5 India Artificial Intelligence Drug R&D Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Artificial Intelligence Drug R&D Market Size and Forecast (2018-2029)
8.3.7 Australia Artificial Intelligence Drug R&D Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Artificial Intelligence Drug R&D Consumption Value by Type (2018-2029)
9.2 South America Artificial Intelligence Drug R&D Consumption Value by Application (2018-2029)
9.3 South America Artificial Intelligence Drug R&D Market Size by Country
9.3.1 South America Artificial Intelligence Drug R&D Consumption Value by Country (2018-2029)
9.3.2 Brazil Artificial Intelligence Drug R&D Market Size and Forecast (2018-2029)
9.3.3 Argentina Artificial Intelligence Drug R&D Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Artificial Intelligence Drug R&D Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Artificial Intelligence Drug R&D Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Artificial Intelligence Drug R&D Market Size by Country
10.3.1 Middle East & Africa Artificial Intelligence Drug R&D Consumption Value by Country (2018-2029)
10.3.2 Turkey Artificial Intelligence Drug R&D Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Artificial Intelligence Drug R&D Market Size and Forecast (2018-2029)
10.3.4 UAE Artificial Intelligence Drug R&D Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Artificial Intelligence Drug R&D Market Drivers
11.2 Artificial Intelligence Drug R&D Market Restraints
11.3 Artificial Intelligence Drug R&D Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Artificial Intelligence Drug R&D Industry Chain
12.2 Artificial Intelligence Drug R&D Upstream Analysis
12.3 Artificial Intelligence Drug R&D Midstream Analysis
12.4 Artificial Intelligence Drug R&D Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Artificial Intelligence Drug R&D
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Artificial Intelligence Drug R&D by Type
1.3.1 Overview: Global Artificial Intelligence Drug R&D Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Artificial Intelligence Drug R&D Consumption Value Market Share by Type in 2022
1.3.3 AI Platfrom
1.3.4 Analytics Service
1.4 Global Artificial Intelligence Drug R&D Market by Application
1.4.1 Overview: Global Artificial Intelligence Drug R&D Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Drug Discovery
1.4.3 Precision Medicine
1.5 Global Artificial Intelligence Drug R&D Market Size & Forecast
1.6 Global Artificial Intelligence Drug R&D Market Size and Forecast by Region
1.6.1 Global Artificial Intelligence Drug R&D Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Artificial Intelligence Drug R&D Market Size by Region, (2018-2029)
1.6.3 North America Artificial Intelligence Drug R&D Market Size and Prospect (2018-2029)
1.6.4 Europe Artificial Intelligence Drug R&D Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Artificial Intelligence Drug R&D Market Size and Prospect (2018-2029)
1.6.6 South America Artificial Intelligence Drug R&D Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Artificial Intelligence Drug R&D Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 IBM Watson
2.1.1 IBM Watson Details
2.1.2 IBM Watson Major Business
2.1.3 IBM Watson Artificial Intelligence Drug R&D Product and Solutions
2.1.4 IBM Watson Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 IBM Watson Recent Developments and Future Plans
2.2 BioXel
2.2.1 BioXel Details
2.2.2 BioXel Major Business
2.2.3 BioXel Artificial Intelligence Drug R&D Product and Solutions
2.2.4 BioXel Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 BioXel Recent Developments and Future Plans
2.3 Insilico Medicine
2.3.1 Insilico Medicine Details
2.3.2 Insilico Medicine Major Business
2.3.3 Insilico Medicine Artificial Intelligence Drug R&D Product and Solutions
2.3.4 Insilico Medicine Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Insilico Medicine Recent Developments and Future Plans
2.4 Gatehouse Bio
2.4.1 Gatehouse Bio Details
2.4.2 Gatehouse Bio Major Business
2.4.3 Gatehouse Bio Artificial Intelligence Drug R&D Product and Solutions
2.4.4 Gatehouse Bio Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Gatehouse Bio Recent Developments and Future Plans
2.5 Google DeepMind
2.5.1 Google DeepMind Details
2.5.2 Google DeepMind Major Business
2.5.3 Google DeepMind Artificial Intelligence Drug R&D Product and Solutions
2.5.4 Google DeepMind Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Google DeepMind Recent Developments and Future Plans
2.6 Genpact Cora
2.6.1 Genpact Cora Details
2.6.2 Genpact Cora Major Business
2.6.3 Genpact Cora Artificial Intelligence Drug R&D Product and Solutions
2.6.4 Genpact Cora Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Genpact Cora Recent Developments and Future Plans
2.7 Cyclica Inc
2.7.1 Cyclica Inc Details
2.7.2 Cyclica Inc Major Business
2.7.3 Cyclica Inc Artificial Intelligence Drug R&D Product and Solutions
2.7.4 Cyclica Inc Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Cyclica Inc Recent Developments and Future Plans
2.8 QuantumBlack
2.8.1 QuantumBlack Details
2.8.2 QuantumBlack Major Business
2.8.3 QuantumBlack Artificial Intelligence Drug R&D Product and Solutions
2.8.4 QuantumBlack Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 QuantumBlack Recent Developments and Future Plans
2.9 Nq Medical
2.9.1 Nq Medical Details
2.9.2 Nq Medical Major Business
2.9.3 Nq Medical Artificial Intelligence Drug R&D Product and Solutions
2.9.4 Nq Medical Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Nq Medical Recent Developments and Future Plans
2.10 Phenomic AI
2.10.1 Phenomic AI Details
2.10.2 Phenomic AI Major Business
2.10.3 Phenomic AI Artificial Intelligence Drug R&D Product and Solutions
2.10.4 Phenomic AI Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Phenomic AI Recent Developments and Future Plans
2.11 Palantir Technologies
2.11.1 Palantir Technologies Details
2.11.2 Palantir Technologies Major Business
2.11.3 Palantir Technologies Artificial Intelligence Drug R&D Product and Solutions
2.11.4 Palantir Technologies Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Palantir Technologies Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Artificial Intelligence Drug R&D Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Artificial Intelligence Drug R&D by Company Revenue
3.2.2 Top 3 Artificial Intelligence Drug R&D Players Market Share in 2022
3.2.3 Top 6 Artificial Intelligence Drug R&D Players Market Share in 2022
3.3 Artificial Intelligence Drug R&D Market: Overall Company Footprint Analysis
3.3.1 Artificial Intelligence Drug R&D Market: Region Footprint
3.3.2 Artificial Intelligence Drug R&D Market: Company Product Type Footprint
3.3.3 Artificial Intelligence Drug R&D Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Artificial Intelligence Drug R&D Consumption Value and Market Share by Type (2018-2023)
4.2 Global Artificial Intelligence Drug R&D Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Artificial Intelligence Drug R&D Consumption Value Market Share by Application (2018-2023)
5.2 Global Artificial Intelligence Drug R&D Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Artificial Intelligence Drug R&D Consumption Value by Type (2018-2029)
6.2 North America Artificial Intelligence Drug R&D Consumption Value by Application (2018-2029)
6.3 North America Artificial Intelligence Drug R&D Market Size by Country
6.3.1 North America Artificial Intelligence Drug R&D Consumption Value by Country (2018-2029)
6.3.2 United States Artificial Intelligence Drug R&D Market Size and Forecast (2018-2029)
6.3.3 Canada Artificial Intelligence Drug R&D Market Size and Forecast (2018-2029)
6.3.4 Mexico Artificial Intelligence Drug R&D Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Artificial Intelligence Drug R&D Consumption Value by Type (2018-2029)
7.2 Europe Artificial Intelligence Drug R&D Consumption Value by Application (2018-2029)
7.3 Europe Artificial Intelligence Drug R&D Market Size by Country
7.3.1 Europe Artificial Intelligence Drug R&D Consumption Value by Country (2018-2029)
7.3.2 Germany Artificial Intelligence Drug R&D Market Size and Forecast (2018-2029)
7.3.3 France Artificial Intelligence Drug R&D Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Artificial Intelligence Drug R&D Market Size and Forecast (2018-2029)
7.3.5 Russia Artificial Intelligence Drug R&D Market Size and Forecast (2018-2029)
7.3.6 Italy Artificial Intelligence Drug R&D Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Artificial Intelligence Drug R&D Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Artificial Intelligence Drug R&D Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Artificial Intelligence Drug R&D Market Size by Region
8.3.1 Asia-Pacific Artificial Intelligence Drug R&D Consumption Value by Region (2018-2029)
8.3.2 China Artificial Intelligence Drug R&D Market Size and Forecast (2018-2029)
8.3.3 Japan Artificial Intelligence Drug R&D Market Size and Forecast (2018-2029)
8.3.4 South Korea Artificial Intelligence Drug R&D Market Size and Forecast (2018-2029)
8.3.5 India Artificial Intelligence Drug R&D Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Artificial Intelligence Drug R&D Market Size and Forecast (2018-2029)
8.3.7 Australia Artificial Intelligence Drug R&D Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Artificial Intelligence Drug R&D Consumption Value by Type (2018-2029)
9.2 South America Artificial Intelligence Drug R&D Consumption Value by Application (2018-2029)
9.3 South America Artificial Intelligence Drug R&D Market Size by Country
9.3.1 South America Artificial Intelligence Drug R&D Consumption Value by Country (2018-2029)
9.3.2 Brazil Artificial Intelligence Drug R&D Market Size and Forecast (2018-2029)
9.3.3 Argentina Artificial Intelligence Drug R&D Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Artificial Intelligence Drug R&D Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Artificial Intelligence Drug R&D Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Artificial Intelligence Drug R&D Market Size by Country
10.3.1 Middle East & Africa Artificial Intelligence Drug R&D Consumption Value by Country (2018-2029)
10.3.2 Turkey Artificial Intelligence Drug R&D Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Artificial Intelligence Drug R&D Market Size and Forecast (2018-2029)
10.3.4 UAE Artificial Intelligence Drug R&D Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Artificial Intelligence Drug R&D Market Drivers
11.2 Artificial Intelligence Drug R&D Market Restraints
11.3 Artificial Intelligence Drug R&D Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Artificial Intelligence Drug R&D Industry Chain
12.2 Artificial Intelligence Drug R&D Upstream Analysis
12.3 Artificial Intelligence Drug R&D Midstream Analysis
12.4 Artificial Intelligence Drug R&D Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Artificial Intelligence Drug R&D Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Artificial Intelligence Drug R&D Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Artificial Intelligence Drug R&D Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Artificial Intelligence Drug R&D Consumption Value by Region (2024-2029) & (USD Million)
Table 5. IBM Watson Company Information, Head Office, and Major Competitors
Table 6. IBM Watson Major Business
Table 7. IBM Watson Artificial Intelligence Drug R&D Product and Solutions
Table 8. IBM Watson Artificial Intelligence Drug R&D Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. IBM Watson Recent Developments and Future Plans
Table 10. BioXel Company Information, Head Office, and Major Competitors
Table 11. BioXel Major Business
Table 12. BioXel Artificial Intelligence Drug R&D Product and Solutions
Table 13. BioXel Artificial Intelligence Drug R&D Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. BioXel Recent Developments and Future Plans
Table 15. Insilico Medicine Company Information, Head Office, and Major Competitors
Table 16. Insilico Medicine Major Business
Table 17. Insilico Medicine Artificial Intelligence Drug R&D Product and Solutions
Table 18. Insilico Medicine Artificial Intelligence Drug R&D Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Insilico Medicine Recent Developments and Future Plans
Table 20. Gatehouse Bio Company Information, Head Office, and Major Competitors
Table 21. Gatehouse Bio Major Business
Table 22. Gatehouse Bio Artificial Intelligence Drug R&D Product and Solutions
Table 23. Gatehouse Bio Artificial Intelligence Drug R&D Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Gatehouse Bio Recent Developments and Future Plans
Table 25. Google DeepMind Company Information, Head Office, and Major Competitors
Table 26. Google DeepMind Major Business
Table 27. Google DeepMind Artificial Intelligence Drug R&D Product and Solutions
Table 28. Google DeepMind Artificial Intelligence Drug R&D Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Google DeepMind Recent Developments and Future Plans
Table 30. Genpact Cora Company Information, Head Office, and Major Competitors
Table 31. Genpact Cora Major Business
Table 32. Genpact Cora Artificial Intelligence Drug R&D Product and Solutions
Table 33. Genpact Cora Artificial Intelligence Drug R&D Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Genpact Cora Recent Developments and Future Plans
Table 35. Cyclica Inc Company Information, Head Office, and Major Competitors
Table 36. Cyclica Inc Major Business
Table 37. Cyclica Inc Artificial Intelligence Drug R&D Product and Solutions
Table 38. Cyclica Inc Artificial Intelligence Drug R&D Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Cyclica Inc Recent Developments and Future Plans
Table 40. QuantumBlack Company Information, Head Office, and Major Competitors
Table 41. QuantumBlack Major Business
Table 42. QuantumBlack Artificial Intelligence Drug R&D Product and Solutions
Table 43. QuantumBlack Artificial Intelligence Drug R&D Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. QuantumBlack Recent Developments and Future Plans
Table 45. Nq Medical Company Information, Head Office, and Major Competitors
Table 46. Nq Medical Major Business
Table 47. Nq Medical Artificial Intelligence Drug R&D Product and Solutions
Table 48. Nq Medical Artificial Intelligence Drug R&D Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Nq Medical Recent Developments and Future Plans
Table 50. Phenomic AI Company Information, Head Office, and Major Competitors
Table 51. Phenomic AI Major Business
Table 52. Phenomic AI Artificial Intelligence Drug R&D Product and Solutions
Table 53. Phenomic AI Artificial Intelligence Drug R&D Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Phenomic AI Recent Developments and Future Plans
Table 55. Palantir Technologies Company Information, Head Office, and Major Competitors
Table 56. Palantir Technologies Major Business
Table 57. Palantir Technologies Artificial Intelligence Drug R&D Product and Solutions
Table 58. Palantir Technologies Artificial Intelligence Drug R&D Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Palantir Technologies Recent Developments and Future Plans
Table 60. Global Artificial Intelligence Drug R&D Revenue (USD Million) by Players (2018-2023)
Table 61. Global Artificial Intelligence Drug R&D Revenue Share by Players (2018-2023)
Table 62. Breakdown of Artificial Intelligence Drug R&D by Company Type (Tier 1, Tier 2, and Tier 3)
Table 63. Market Position of Players in Artificial Intelligence Drug R&D, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 64. Head Office of Key Artificial Intelligence Drug R&D Players
Table 65. Artificial Intelligence Drug R&D Market: Company Product Type Footprint
Table 66. Artificial Intelligence Drug R&D Market: Company Product Application Footprint
Table 67. Artificial Intelligence Drug R&D New Market Entrants and Barriers to Market Entry
Table 68. Artificial Intelligence Drug R&D Mergers, Acquisition, Agreements, and Collaborations
Table 69. Global Artificial Intelligence Drug R&D Consumption Value (USD Million) by Type (2018-2023)
Table 70. Global Artificial Intelligence Drug R&D Consumption Value Share by Type (2018-2023)
Table 71. Global Artificial Intelligence Drug R&D Consumption Value Forecast by Type (2024-2029)
Table 72. Global Artificial Intelligence Drug R&D Consumption Value by Application (2018-2023)
Table 73. Global Artificial Intelligence Drug R&D Consumption Value Forecast by Application (2024-2029)
Table 74. North America Artificial Intelligence Drug R&D Consumption Value by Type (2018-2023) & (USD Million)
Table 75. North America Artificial Intelligence Drug R&D Consumption Value by Type (2024-2029) & (USD Million)
Table 76. North America Artificial Intelligence Drug R&D Consumption Value by Application (2018-2023) & (USD Million)
Table 77. North America Artificial Intelligence Drug R&D Consumption Value by Application (2024-2029) & (USD Million)
Table 78. North America Artificial Intelligence Drug R&D Consumption Value by Country (2018-2023) & (USD Million)
Table 79. North America Artificial Intelligence Drug R&D Consumption Value by Country (2024-2029) & (USD Million)
Table 80. Europe Artificial Intelligence Drug R&D Consumption Value by Type (2018-2023) & (USD Million)
Table 81. Europe Artificial Intelligence Drug R&D Consumption Value by Type (2024-2029) & (USD Million)
Table 82. Europe Artificial Intelligence Drug R&D Consumption Value by Application (2018-2023) & (USD Million)
Table 83. Europe Artificial Intelligence Drug R&D Consumption Value by Application (2024-2029) & (USD Million)
Table 84. Europe Artificial Intelligence Drug R&D Consumption Value by Country (2018-2023) & (USD Million)
Table 85. Europe Artificial Intelligence Drug R&D Consumption Value by Country (2024-2029) & (USD Million)
Table 86. Asia-Pacific Artificial Intelligence Drug R&D Consumption Value by Type (2018-2023) & (USD Million)
Table 87. Asia-Pacific Artificial Intelligence Drug R&D Consumption Value by Type (2024-2029) & (USD Million)
Table 88. Asia-Pacific Artificial Intelligence Drug R&D Consumption Value by Application (2018-2023) & (USD Million)
Table 89. Asia-Pacific Artificial Intelligence Drug R&D Consumption Value by Application (2024-2029) & (USD Million)
Table 90. Asia-Pacific Artificial Intelligence Drug R&D Consumption Value by Region (2018-2023) & (USD Million)
Table 91. Asia-Pacific Artificial Intelligence Drug R&D Consumption Value by Region (2024-2029) & (USD Million)
Table 92. South America Artificial Intelligence Drug R&D Consumption Value by Type (2018-2023) & (USD Million)
Table 93. South America Artificial Intelligence Drug R&D Consumption Value by Type (2024-2029) & (USD Million)
Table 94. South America Artificial Intelligence Drug R&D Consumption Value by Application (2018-2023) & (USD Million)
Table 95. South America Artificial Intelligence Drug R&D Consumption Value by Application (2024-2029) & (USD Million)
Table 96. South America Artificial Intelligence Drug R&D Consumption Value by Country (2018-2023) & (USD Million)
Table 97. South America Artificial Intelligence Drug R&D Consumption Value by Country (2024-2029) & (USD Million)
Table 98. Middle East & Africa Artificial Intelligence Drug R&D Consumption Value by Type (2018-2023) & (USD Million)
Table 99. Middle East & Africa Artificial Intelligence Drug R&D Consumption Value by Type (2024-2029) & (USD Million)
Table 100. Middle East & Africa Artificial Intelligence Drug R&D Consumption Value by Application (2018-2023) & (USD Million)
Table 101. Middle East & Africa Artificial Intelligence Drug R&D Consumption Value by Application (2024-2029) & (USD Million)
Table 102. Middle East & Africa Artificial Intelligence Drug R&D Consumption Value by Country (2018-2023) & (USD Million)
Table 103. Middle East & Africa Artificial Intelligence Drug R&D Consumption Value by Country (2024-2029) & (USD Million)
Table 104. Artificial Intelligence Drug R&D Raw Material
Table 105. Key Suppliers of Artificial Intelligence Drug R&D Raw Materials
Table 1. Global Artificial Intelligence Drug R&D Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Artificial Intelligence Drug R&D Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Artificial Intelligence Drug R&D Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Artificial Intelligence Drug R&D Consumption Value by Region (2024-2029) & (USD Million)
Table 5. IBM Watson Company Information, Head Office, and Major Competitors
Table 6. IBM Watson Major Business
Table 7. IBM Watson Artificial Intelligence Drug R&D Product and Solutions
Table 8. IBM Watson Artificial Intelligence Drug R&D Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. IBM Watson Recent Developments and Future Plans
Table 10. BioXel Company Information, Head Office, and Major Competitors
Table 11. BioXel Major Business
Table 12. BioXel Artificial Intelligence Drug R&D Product and Solutions
Table 13. BioXel Artificial Intelligence Drug R&D Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. BioXel Recent Developments and Future Plans
Table 15. Insilico Medicine Company Information, Head Office, and Major Competitors
Table 16. Insilico Medicine Major Business
Table 17. Insilico Medicine Artificial Intelligence Drug R&D Product and Solutions
Table 18. Insilico Medicine Artificial Intelligence Drug R&D Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Insilico Medicine Recent Developments and Future Plans
Table 20. Gatehouse Bio Company Information, Head Office, and Major Competitors
Table 21. Gatehouse Bio Major Business
Table 22. Gatehouse Bio Artificial Intelligence Drug R&D Product and Solutions
Table 23. Gatehouse Bio Artificial Intelligence Drug R&D Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Gatehouse Bio Recent Developments and Future Plans
Table 25. Google DeepMind Company Information, Head Office, and Major Competitors
Table 26. Google DeepMind Major Business
Table 27. Google DeepMind Artificial Intelligence Drug R&D Product and Solutions
Table 28. Google DeepMind Artificial Intelligence Drug R&D Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Google DeepMind Recent Developments and Future Plans
Table 30. Genpact Cora Company Information, Head Office, and Major Competitors
Table 31. Genpact Cora Major Business
Table 32. Genpact Cora Artificial Intelligence Drug R&D Product and Solutions
Table 33. Genpact Cora Artificial Intelligence Drug R&D Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Genpact Cora Recent Developments and Future Plans
Table 35. Cyclica Inc Company Information, Head Office, and Major Competitors
Table 36. Cyclica Inc Major Business
Table 37. Cyclica Inc Artificial Intelligence Drug R&D Product and Solutions
Table 38. Cyclica Inc Artificial Intelligence Drug R&D Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Cyclica Inc Recent Developments and Future Plans
Table 40. QuantumBlack Company Information, Head Office, and Major Competitors
Table 41. QuantumBlack Major Business
Table 42. QuantumBlack Artificial Intelligence Drug R&D Product and Solutions
Table 43. QuantumBlack Artificial Intelligence Drug R&D Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. QuantumBlack Recent Developments and Future Plans
Table 45. Nq Medical Company Information, Head Office, and Major Competitors
Table 46. Nq Medical Major Business
Table 47. Nq Medical Artificial Intelligence Drug R&D Product and Solutions
Table 48. Nq Medical Artificial Intelligence Drug R&D Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Nq Medical Recent Developments and Future Plans
Table 50. Phenomic AI Company Information, Head Office, and Major Competitors
Table 51. Phenomic AI Major Business
Table 52. Phenomic AI Artificial Intelligence Drug R&D Product and Solutions
Table 53. Phenomic AI Artificial Intelligence Drug R&D Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Phenomic AI Recent Developments and Future Plans
Table 55. Palantir Technologies Company Information, Head Office, and Major Competitors
Table 56. Palantir Technologies Major Business
Table 57. Palantir Technologies Artificial Intelligence Drug R&D Product and Solutions
Table 58. Palantir Technologies Artificial Intelligence Drug R&D Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Palantir Technologies Recent Developments and Future Plans
Table 60. Global Artificial Intelligence Drug R&D Revenue (USD Million) by Players (2018-2023)
Table 61. Global Artificial Intelligence Drug R&D Revenue Share by Players (2018-2023)
Table 62. Breakdown of Artificial Intelligence Drug R&D by Company Type (Tier 1, Tier 2, and Tier 3)
Table 63. Market Position of Players in Artificial Intelligence Drug R&D, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 64. Head Office of Key Artificial Intelligence Drug R&D Players
Table 65. Artificial Intelligence Drug R&D Market: Company Product Type Footprint
Table 66. Artificial Intelligence Drug R&D Market: Company Product Application Footprint
Table 67. Artificial Intelligence Drug R&D New Market Entrants and Barriers to Market Entry
Table 68. Artificial Intelligence Drug R&D Mergers, Acquisition, Agreements, and Collaborations
Table 69. Global Artificial Intelligence Drug R&D Consumption Value (USD Million) by Type (2018-2023)
Table 70. Global Artificial Intelligence Drug R&D Consumption Value Share by Type (2018-2023)
Table 71. Global Artificial Intelligence Drug R&D Consumption Value Forecast by Type (2024-2029)
Table 72. Global Artificial Intelligence Drug R&D Consumption Value by Application (2018-2023)
Table 73. Global Artificial Intelligence Drug R&D Consumption Value Forecast by Application (2024-2029)
Table 74. North America Artificial Intelligence Drug R&D Consumption Value by Type (2018-2023) & (USD Million)
Table 75. North America Artificial Intelligence Drug R&D Consumption Value by Type (2024-2029) & (USD Million)
Table 76. North America Artificial Intelligence Drug R&D Consumption Value by Application (2018-2023) & (USD Million)
Table 77. North America Artificial Intelligence Drug R&D Consumption Value by Application (2024-2029) & (USD Million)
Table 78. North America Artificial Intelligence Drug R&D Consumption Value by Country (2018-2023) & (USD Million)
Table 79. North America Artificial Intelligence Drug R&D Consumption Value by Country (2024-2029) & (USD Million)
Table 80. Europe Artificial Intelligence Drug R&D Consumption Value by Type (2018-2023) & (USD Million)
Table 81. Europe Artificial Intelligence Drug R&D Consumption Value by Type (2024-2029) & (USD Million)
Table 82. Europe Artificial Intelligence Drug R&D Consumption Value by Application (2018-2023) & (USD Million)
Table 83. Europe Artificial Intelligence Drug R&D Consumption Value by Application (2024-2029) & (USD Million)
Table 84. Europe Artificial Intelligence Drug R&D Consumption Value by Country (2018-2023) & (USD Million)
Table 85. Europe Artificial Intelligence Drug R&D Consumption Value by Country (2024-2029) & (USD Million)
Table 86. Asia-Pacific Artificial Intelligence Drug R&D Consumption Value by Type (2018-2023) & (USD Million)
Table 87. Asia-Pacific Artificial Intelligence Drug R&D Consumption Value by Type (2024-2029) & (USD Million)
Table 88. Asia-Pacific Artificial Intelligence Drug R&D Consumption Value by Application (2018-2023) & (USD Million)
Table 89. Asia-Pacific Artificial Intelligence Drug R&D Consumption Value by Application (2024-2029) & (USD Million)
Table 90. Asia-Pacific Artificial Intelligence Drug R&D Consumption Value by Region (2018-2023) & (USD Million)
Table 91. Asia-Pacific Artificial Intelligence Drug R&D Consumption Value by Region (2024-2029) & (USD Million)
Table 92. South America Artificial Intelligence Drug R&D Consumption Value by Type (2018-2023) & (USD Million)
Table 93. South America Artificial Intelligence Drug R&D Consumption Value by Type (2024-2029) & (USD Million)
Table 94. South America Artificial Intelligence Drug R&D Consumption Value by Application (2018-2023) & (USD Million)
Table 95. South America Artificial Intelligence Drug R&D Consumption Value by Application (2024-2029) & (USD Million)
Table 96. South America Artificial Intelligence Drug R&D Consumption Value by Country (2018-2023) & (USD Million)
Table 97. South America Artificial Intelligence Drug R&D Consumption Value by Country (2024-2029) & (USD Million)
Table 98. Middle East & Africa Artificial Intelligence Drug R&D Consumption Value by Type (2018-2023) & (USD Million)
Table 99. Middle East & Africa Artificial Intelligence Drug R&D Consumption Value by Type (2024-2029) & (USD Million)
Table 100. Middle East & Africa Artificial Intelligence Drug R&D Consumption Value by Application (2018-2023) & (USD Million)
Table 101. Middle East & Africa Artificial Intelligence Drug R&D Consumption Value by Application (2024-2029) & (USD Million)
Table 102. Middle East & Africa Artificial Intelligence Drug R&D Consumption Value by Country (2018-2023) & (USD Million)
Table 103. Middle East & Africa Artificial Intelligence Drug R&D Consumption Value by Country (2024-2029) & (USD Million)
Table 104. Artificial Intelligence Drug R&D Raw Material
Table 105. Key Suppliers of Artificial Intelligence Drug R&D Raw Materials
LIST OF FIGURES
Figure 1. Artificial Intelligence Drug R&D Picture
Figure 2. Global Artificial Intelligence Drug R&D Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Artificial Intelligence Drug R&D Consumption Value Market Share by Type in 2022
Figure 4. AI Platfrom
Figure 5. Analytics Service
Figure 6. Global Artificial Intelligence Drug R&D Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 7. Artificial Intelligence Drug R&D Consumption Value Market Share by Application in 2022
Figure 8. Drug Discovery Picture
Figure 9. Precision Medicine Picture
Figure 10. Global Artificial Intelligence Drug R&D Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 11. Global Artificial Intelligence Drug R&D Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 12. Global Market Artificial Intelligence Drug R&D Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 13. Global Artificial Intelligence Drug R&D Consumption Value Market Share by Region (2018-2029)
Figure 14. Global Artificial Intelligence Drug R&D Consumption Value Market Share by Region in 2022
Figure 15. North America Artificial Intelligence Drug R&D Consumption Value (2018-2029) & (USD Million)
Figure 16. Europe Artificial Intelligence Drug R&D Consumption Value (2018-2029) & (USD Million)
Figure 17. Asia-Pacific Artificial Intelligence Drug R&D Consumption Value (2018-2029) & (USD Million)
Figure 18. South America Artificial Intelligence Drug R&D Consumption Value (2018-2029) & (USD Million)
Figure 19. Middle East and Africa Artificial Intelligence Drug R&D Consumption Value (2018-2029) & (USD Million)
Figure 20. Global Artificial Intelligence Drug R&D Revenue Share by Players in 2022
Figure 21. Artificial Intelligence Drug R&D Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 22. Global Top 3 Players Artificial Intelligence Drug R&D Market Share in 2022
Figure 23. Global Top 6 Players Artificial Intelligence Drug R&D Market Share in 2022
Figure 24. Global Artificial Intelligence Drug R&D Consumption Value Share by Type (2018-2023)
Figure 25. Global Artificial Intelligence Drug R&D Market Share Forecast by Type (2024-2029)
Figure 26. Global Artificial Intelligence Drug R&D Consumption Value Share by Application (2018-2023)
Figure 27. Global Artificial Intelligence Drug R&D Market Share Forecast by Application (2024-2029)
Figure 28. North America Artificial Intelligence Drug R&D Consumption Value Market Share by Type (2018-2029)
Figure 29. North America Artificial Intelligence Drug R&D Consumption Value Market Share by Application (2018-2029)
Figure 30. North America Artificial Intelligence Drug R&D Consumption Value Market Share by Country (2018-2029)
Figure 31. United States Artificial Intelligence Drug R&D Consumption Value (2018-2029) & (USD Million)
Figure 32. Canada Artificial Intelligence Drug R&D Consumption Value (2018-2029) & (USD Million)
Figure 33. Mexico Artificial Intelligence Drug R&D Consumption Value (2018-2029) & (USD Million)
Figure 34. Europe Artificial Intelligence Drug R&D Consumption Value Market Share by Type (2018-2029)
Figure 35. Europe Artificial Intelligence Drug R&D Consumption Value Market Share by Application (2018-2029)
Figure 36. Europe Artificial Intelligence Drug R&D Consumption Value Market Share by Country (2018-2029)
Figure 37. Germany Artificial Intelligence Drug R&D Consumption Value (2018-2029) & (USD Million)
Figure 38. France Artificial Intelligence Drug R&D Consumption Value (2018-2029) & (USD Million)
Figure 39. United Kingdom Artificial Intelligence Drug R&D Consumption Value (2018-2029) & (USD Million)
Figure 40. Russia Artificial Intelligence Drug R&D Consumption Value (2018-2029) & (USD Million)
Figure 41. Italy Artificial Intelligence Drug R&D Consumption Value (2018-2029) & (USD Million)
Figure 42. Asia-Pacific Artificial Intelligence Drug R&D Consumption Value Market Share by Type (2018-2029)
Figure 43. Asia-Pacific Artificial Intelligence Drug R&D Consumption Value Market Share by Application (2018-2029)
Figure 44. Asia-Pacific Artificial Intelligence Drug R&D Consumption Value Market Share by Region (2018-2029)
Figure 45. China Artificial Intelligence Drug R&D Consumption Value (2018-2029) & (USD Million)
Figure 46. Japan Artificial Intelligence Drug R&D Consumption Value (2018-2029) & (USD Million)
Figure 47. South Korea Artificial Intelligence Drug R&D Consumption Value (2018-2029) & (USD Million)
Figure 48. India Artificial Intelligence Drug R&D Consumption Value (2018-2029) & (USD Million)
Figure 49. Southeast Asia Artificial Intelligence Drug R&D Consumption Value (2018-2029) & (USD Million)
Figure 50. Australia Artificial Intelligence Drug R&D Consumption Value (2018-2029) & (USD Million)
Figure 51. South America Artificial Intelligence Drug R&D Consumption Value Market Share by Type (2018-2029)
Figure 52. South America Artificial Intelligence Drug R&D Consumption Value Market Share by Application (2018-2029)
Figure 53. South America Artificial Intelligence Drug R&D Consumption Value Market Share by Country (2018-2029)
Figure 54. Brazil Artificial Intelligence Drug R&D Consumption Value (2018-2029) & (USD Million)
Figure 55. Argentina Artificial Intelligence Drug R&D Consumption Value (2018-2029) & (USD Million)
Figure 56. Middle East and Africa Artificial Intelligence Drug R&D Consumption Value Market Share by Type (2018-2029)
Figure 57. Middle East and Africa Artificial Intelligence Drug R&D Consumption Value Market Share by Application (2018-2029)
Figure 58. Middle East and Africa Artificial Intelligence Drug R&D Consumption Value Market Share by Country (2018-2029)
Figure 59. Turkey Artificial Intelligence Drug R&D Consumption Value (2018-2029) & (USD Million)
Figure 60. Saudi Arabia Artificial Intelligence Drug R&D Consumption Value (2018-2029) & (USD Million)
Figure 61. UAE Artificial Intelligence Drug R&D Consumption Value (2018-2029) & (USD Million)
Figure 62. Artificial Intelligence Drug R&D Market Drivers
Figure 63. Artificial Intelligence Drug R&D Market Restraints
Figure 64. Artificial Intelligence Drug R&D Market Trends
Figure 65. Porters Five Forces Analysis
Figure 66. Manufacturing Cost Structure Analysis of Artificial Intelligence Drug R&D in 2022
Figure 67. Manufacturing Process Analysis of Artificial Intelligence Drug R&D
Figure 68. Artificial Intelligence Drug R&D Industrial Chain
Figure 69. Methodology
Figure 70. Research Process and Data Source
Figure 1. Artificial Intelligence Drug R&D Picture
Figure 2. Global Artificial Intelligence Drug R&D Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Artificial Intelligence Drug R&D Consumption Value Market Share by Type in 2022
Figure 4. AI Platfrom
Figure 5. Analytics Service
Figure 6. Global Artificial Intelligence Drug R&D Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 7. Artificial Intelligence Drug R&D Consumption Value Market Share by Application in 2022
Figure 8. Drug Discovery Picture
Figure 9. Precision Medicine Picture
Figure 10. Global Artificial Intelligence Drug R&D Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 11. Global Artificial Intelligence Drug R&D Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 12. Global Market Artificial Intelligence Drug R&D Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 13. Global Artificial Intelligence Drug R&D Consumption Value Market Share by Region (2018-2029)
Figure 14. Global Artificial Intelligence Drug R&D Consumption Value Market Share by Region in 2022
Figure 15. North America Artificial Intelligence Drug R&D Consumption Value (2018-2029) & (USD Million)
Figure 16. Europe Artificial Intelligence Drug R&D Consumption Value (2018-2029) & (USD Million)
Figure 17. Asia-Pacific Artificial Intelligence Drug R&D Consumption Value (2018-2029) & (USD Million)
Figure 18. South America Artificial Intelligence Drug R&D Consumption Value (2018-2029) & (USD Million)
Figure 19. Middle East and Africa Artificial Intelligence Drug R&D Consumption Value (2018-2029) & (USD Million)
Figure 20. Global Artificial Intelligence Drug R&D Revenue Share by Players in 2022
Figure 21. Artificial Intelligence Drug R&D Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 22. Global Top 3 Players Artificial Intelligence Drug R&D Market Share in 2022
Figure 23. Global Top 6 Players Artificial Intelligence Drug R&D Market Share in 2022
Figure 24. Global Artificial Intelligence Drug R&D Consumption Value Share by Type (2018-2023)
Figure 25. Global Artificial Intelligence Drug R&D Market Share Forecast by Type (2024-2029)
Figure 26. Global Artificial Intelligence Drug R&D Consumption Value Share by Application (2018-2023)
Figure 27. Global Artificial Intelligence Drug R&D Market Share Forecast by Application (2024-2029)
Figure 28. North America Artificial Intelligence Drug R&D Consumption Value Market Share by Type (2018-2029)
Figure 29. North America Artificial Intelligence Drug R&D Consumption Value Market Share by Application (2018-2029)
Figure 30. North America Artificial Intelligence Drug R&D Consumption Value Market Share by Country (2018-2029)
Figure 31. United States Artificial Intelligence Drug R&D Consumption Value (2018-2029) & (USD Million)
Figure 32. Canada Artificial Intelligence Drug R&D Consumption Value (2018-2029) & (USD Million)
Figure 33. Mexico Artificial Intelligence Drug R&D Consumption Value (2018-2029) & (USD Million)
Figure 34. Europe Artificial Intelligence Drug R&D Consumption Value Market Share by Type (2018-2029)
Figure 35. Europe Artificial Intelligence Drug R&D Consumption Value Market Share by Application (2018-2029)
Figure 36. Europe Artificial Intelligence Drug R&D Consumption Value Market Share by Country (2018-2029)
Figure 37. Germany Artificial Intelligence Drug R&D Consumption Value (2018-2029) & (USD Million)
Figure 38. France Artificial Intelligence Drug R&D Consumption Value (2018-2029) & (USD Million)
Figure 39. United Kingdom Artificial Intelligence Drug R&D Consumption Value (2018-2029) & (USD Million)
Figure 40. Russia Artificial Intelligence Drug R&D Consumption Value (2018-2029) & (USD Million)
Figure 41. Italy Artificial Intelligence Drug R&D Consumption Value (2018-2029) & (USD Million)
Figure 42. Asia-Pacific Artificial Intelligence Drug R&D Consumption Value Market Share by Type (2018-2029)
Figure 43. Asia-Pacific Artificial Intelligence Drug R&D Consumption Value Market Share by Application (2018-2029)
Figure 44. Asia-Pacific Artificial Intelligence Drug R&D Consumption Value Market Share by Region (2018-2029)
Figure 45. China Artificial Intelligence Drug R&D Consumption Value (2018-2029) & (USD Million)
Figure 46. Japan Artificial Intelligence Drug R&D Consumption Value (2018-2029) & (USD Million)
Figure 47. South Korea Artificial Intelligence Drug R&D Consumption Value (2018-2029) & (USD Million)
Figure 48. India Artificial Intelligence Drug R&D Consumption Value (2018-2029) & (USD Million)
Figure 49. Southeast Asia Artificial Intelligence Drug R&D Consumption Value (2018-2029) & (USD Million)
Figure 50. Australia Artificial Intelligence Drug R&D Consumption Value (2018-2029) & (USD Million)
Figure 51. South America Artificial Intelligence Drug R&D Consumption Value Market Share by Type (2018-2029)
Figure 52. South America Artificial Intelligence Drug R&D Consumption Value Market Share by Application (2018-2029)
Figure 53. South America Artificial Intelligence Drug R&D Consumption Value Market Share by Country (2018-2029)
Figure 54. Brazil Artificial Intelligence Drug R&D Consumption Value (2018-2029) & (USD Million)
Figure 55. Argentina Artificial Intelligence Drug R&D Consumption Value (2018-2029) & (USD Million)
Figure 56. Middle East and Africa Artificial Intelligence Drug R&D Consumption Value Market Share by Type (2018-2029)
Figure 57. Middle East and Africa Artificial Intelligence Drug R&D Consumption Value Market Share by Application (2018-2029)
Figure 58. Middle East and Africa Artificial Intelligence Drug R&D Consumption Value Market Share by Country (2018-2029)
Figure 59. Turkey Artificial Intelligence Drug R&D Consumption Value (2018-2029) & (USD Million)
Figure 60. Saudi Arabia Artificial Intelligence Drug R&D Consumption Value (2018-2029) & (USD Million)
Figure 61. UAE Artificial Intelligence Drug R&D Consumption Value (2018-2029) & (USD Million)
Figure 62. Artificial Intelligence Drug R&D Market Drivers
Figure 63. Artificial Intelligence Drug R&D Market Restraints
Figure 64. Artificial Intelligence Drug R&D Market Trends
Figure 65. Porters Five Forces Analysis
Figure 66. Manufacturing Cost Structure Analysis of Artificial Intelligence Drug R&D in 2022
Figure 67. Manufacturing Process Analysis of Artificial Intelligence Drug R&D
Figure 68. Artificial Intelligence Drug R&D Industrial Chain
Figure 69. Methodology
Figure 70. Research Process and Data Source
